Restor3d will acquire all of the outstanding stock shares of Conformis in cash, paying a 96 percent premium per share on the June 22 closing price, according to a press release.
Conformis’ board of directors unanimously approved the transaction, saying that it is in the best interests of company stockholders. The transaction is expected to close at the end of the third quarter, subject to customary closing conditions.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
